ANVS
Annovis Bio, Inc.
1.92
3700 x undefined
1400 x undefined
bid
ask
+
0.06
3.23%
2550 @ 07:02 AM
1.87 -0.05 (2.51%)
| Ytd | -44.51% | |
| 1y | -17.60% |
1.87
day range
1.96
1.54
52 week range
5.50
| Open | 1.88 | Prev Close | 1.86 | Low | 1.87 | High | 1.96 | Mkt Cap | 81.68M |
| Vol | 708.78K | Avg Vol | 1.24M | EPS | -1.71 | P/E | N/A | Forward P/E | -2.77 |
| Beta | 1.70 | Short Ratio | 6.21 | Inst. Own | 8.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.95 | 200-d Avg | 2.54 | 1yr Est | 34.80 |
| Income Statement | |||
| Operating Expenses | 18.01M | ||
| Research and Development Expense | 16.72M | ||
| Selling, General and Administrative Expense | 1.29M | ||
| Operating Income | -18.01M | ||
| Net Income | -17.61M | ||
| Net Income Common Stock | -17.61M | ||
| Net Income Common Stock (USD) | -17.61M | ||
| Consolidated Income | -17.61M | ||
| Earnings per Basic Share | -0.63 | ||
| Earnings per Basic Share (USD) | -0.63 | ||
| Earnings per Diluted Share | -0.63 | ||
| Earning Before Interest & Taxes (EBIT) | -17.61M | ||
| Earning Before Interest & Taxes (USD) | -17.61M | ||
| Weighted Average Shares | 27.85M | ||
| Weighted Average Shares Diluted | 27.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.22M | ||
| Cash and Equivalents (USD) | 14.22M | ||
| Current Assets | 16.24M | ||
| Total Assets | 16.24M | ||
| Current Liabilities | 12.79M | ||
| Total Liabilities | 13.12M | ||
| Accumulated Retained Earnings (Deficit) | -181.31M | ||
| Shareholders Equity | 3.13M | ||
| Shareholders Equity (USD) | 3.13M | ||
| Liabilities Non-Current | 327.00K | ||
| Trade and Non-Trade Payables | 5.28M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.70M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.31M | ||
| Issuance (Purchase) of Equity Shares | 3.70M | ||
| Net Cash Flow from Operations | -9.01M | ||
| Share Based Compensation | 182.82K | ||